After the due procedure, the Collector of the concerned district...
Category:
Health
Latest
Study provides insights into heart inflammation post COVID-19 vaccination
Lead researcher Carrie Lucas, associate professor of immunobiology...
Cigarette butts leak deadly toxins into environment, study finds
"The filter is full of thousands of toxic chemicals and...
COVID-19 caseload in India rises to 96.44 lakh with 36,011 new cases
The number of people who have recuperated from the disease surged to 91,00,792 pushing the national recovery rate to 94.37 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
There are 4,03,248 active coronavirus infections in the country which comprises 4.18 per cent of the total caseload, the data stated.
Pfizer seeks emergency approval for COVID-19 vaccine in India, media say
The U.S. company, whose vaccine was recently approved by the British government, has written to the Drugs Controller General of India (DCGI), CNN-News18 reported citing a government source.Officials at the DCGI and the health ministry did not respond to requests for comment. A government official, however, told Reuters that no application had been received as of Saturday night.
COVID-19 could push number of people living in extreme poverty to over 1 billion by 2030: UN
“Severe long-term effects of the COVID-19 pandemic could push an additional 207 million people into extreme poverty on top of the current pandemic trajectory, bringing the total to over 1 billion by 2030,” noted the study.
The ‘Baseline COVID’ scenario, based on current mortality rates and the most recent growth projections by the International Monetary Fund (IMF), would result in 44 million more people living in extreme poverty by 2030 compared to the development trajectory the world was on before the pandemic.
Almost all COVID-19 patients develop antibodies: WHO
“What we understand is 90 to 100 per cent of people who are infected with the virus do develop an antibody response, whether you have mild infection or asymptomatic infection all the way to severe infection. And we’re still learning how long that antibody response lasts, how strong it is, how it relates to immunity from another infection, and how long that lasts,” Van Kerkhove, an expert on epidemiology, said at a virtual press briefing.
Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups
Scientists have raised concerns about the speed at which Russia has worked, giving the regulatory go-ahead for its vaccines and launching mass vaccinations before full trials to test its safety and efficacy had been completed.
Now that vaccines are coming, what about poor countries?
By Andreas Kluth It’s now just a matter of weeks before shoulders are bared, syringes primed and vaccines injected. If last year was the one that gave Covid-19 its name and 2020 was defined by masks, gowns and swabs, 2021 will be the year of the...
Bharat Biotech says COVAXIN efficacious, safe, as Anil Vij tests positive for Covid-19
The drug firm said its vaccine Covaxin is based on two dose schedule and its efficacy is determined 14 days post the second dosage. “COVAXIN clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose,” Bharat Biotech said in a statement.
COVID-19: 36,652 new cases take India’s virus tally to 96,08,211
The COVID-19 case fatality rate was recorded at 1.45 per cent
There are 4,09,689 active cases of coronavirus infection in the country which comprises 4.26 per cent of the total caseload, the data stated
Even with vaccines, airport testing Is here for the long haul
There’s data to support the idea that testing could reestablish consumer confidence. In a study published by the Global Business Travel Association (GBTA) in October, 76% of respondents said that rapid testing prior to departure—with waived quarantining requirements for those who test negative—would be the best way to open up international travel.
COVID-19 caseload surges to 95.71 lakh; recoveries cross 90 lakh
The number of people who have recuperated from the disease surged to 90,16,289 pushing the national recovery rate to 94.20 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The active COVID-19 caseload continued to remain below 5 lakh.There are 4,16,082 active coronavirus infections in the country which comprises 4.35 per cent of the total caseload, the data stated.